WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues

By N. Shinton. 2007

8,197 citations recorded by the source corpus.

Subfields: Emergency Medicine

View Paper: https://www.semanticscholar.org/paper/c0739bfa2ced1b1256d90d85dbcd4fcb1d0c915e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Baccarani
2. J. Cortes
3. George W. Wright
4. H. Kantarjian
5. M. Deininger
6. A. Hochhaus
7. Brian J. Druker
8. G. Saglio

Citations in the corpus

• Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. (2012, methodology): “Patient Population We used pretreatment tumor biopsies taken from two independent cohorts of patients diagnosed with de novo DLBCL according to WHO classification (2008) criteria.(1) Patients were initially selected because they were linked to clinical information, including baseline characteristics”